Clin2
NCT05704491Possibly a fitRecruiting

AI screening for diabetic eye damage

Diabetes Mellitus

Part of Hormones & metabolism clinical trials.

This study tests an artificial intelligence (AI) screening method to detect diabetic retinopathy, a type of eye damage caused by diabetes. It may help find eye changes earlier, so treatment can be planned sooner.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
100 people
Ages
18 years and older
Study type
Observational

Who can take part

  • You have been diagnosed with diabetes
  • You have had diabetes for at least 5 years
  • You are over 18 years old
  • You can understand the study and give consent
  • You can speak and read German, or you have an interpreter
  • You have not had laser treatment for your eye problem before

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06763952Not yet recruiting
AI eye test to prevent vision loss from diabetes

This study uses artificial intelligence to check for early signs of diabetic eye disease in people who haven't had an eye exam in the past year. It aims to catch problems early and prevent vision loss.

Madison, Wisconsin
NCT07559292Enrolling by invitation
AI screening to catch diabetes eye problems early

This study tests whether artificial intelligence can help detect early signs of diabetes-related eye damage before vision loss happens. You'd be screened at your regular doctor visit using a new AI tool, which could catch problems earlier than usual.

Madison, Wisconsin
NCT07378956Recruiting
AI eye screening for diabetes patients

This study uses an artificial intelligence (AI) tool to analyze eye images in people with type 2 diabetes. The goal is to see if the AI can help detect early signs of diabetic eye disease, so you can get the right care sooner.

Incheon, Gyeonggi-do
NCT06879834Recruiting
AI software for diabetic eye screening

This study tests an AI platform that checks for diabetic retinopathy, a common eye problem in people with diabetes. It aims to see if the AI can spot signs of damage early, so you can get treatment sooner.

Odesa
NCT07151001Recruiting
AI test for early diabetic eye disease (retinopathy)

This trial uses an AI system to test if it can find early signs of diabetic eye disease (diabetic retinopathy) in people with diabetes. If you have diabetes but no known eye problems, the AI might help catch issues early.

Richmond Hill, New York
NCT07378891Enrolling by invitation
AI eye screening for early diabetic retinopathy

This study uses artificial intelligence (AI) to look at photos of the back of your eye (retina) to find early signs of diabetic eye disease. It aims to catch problems before they worsen, so you can get treatment sooner.

Tübingen

Hear when a new Diabetes Mellitus trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.